Clinical Trial Update: Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging [Phase 2]

View source ↗

Summary

Phase 2 trial investigating hypoxic changes in hepatocellular carcinoma after transarterial chemoembolization and stereotactic radiation using FMISO PET imaging…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2021-02-21